Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Prostate Cancer

Free Subscription 22.09.2025 1 Am J Surg Pathol 1 Br J Cancer 2 Clin Imaging 2 Int J Cancer 2 Int J Urol 1 J Magn Reson Imaging 1 Nat Rev Urol 1 PLoS One 1 Prostate 1 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg Pathol

1. ZONG Y, Sharobim M, Lawrence EM, Hu R, et al
   Psammomatous Calcifications Identified in Targeted Needle Biopsies and Radical Prostatectomy From IDH1 Mutant Prostatic Adenocarcinoma : Case Report and Literature Review.
   Am J Surg Pathol. 2025;49:1090-1096.
   PubMed         Abstract available
   
   

   
   Br J Cancer

2. MAY M, Gilfrich C, Enzinger B, Brookman-May S, et al
   Exercise oncology in prostate cancer: from observational insight to prescriptive precision.
   Br J Cancer. 2025 Sep 16. doi: 10.1038/s41416-025-03205.
   PubMed        
   
   

   
   Clin Imaging

3. SIMON BD, Harmon SA, Turkbey B
   Reply to "A critical appraisal and methodological inquiry into an automated multimodal deep learning model for predicting biochemical recurrence in prostate cancer".
   Clin Imaging. 2025 Sep 13:110616. doi: 10.1016/j.clinimag.2025.110616.
   PubMed        
   
   
4. APHALE P, Dokania S, Shekhar H
   A critical appraisal and methodological inquiry into an automated multimodal deep learning model for predicting biochemical recurrence in prostate cancer.
   Clin Imaging. 2025 Sep 11:110615. doi: 10.1016/j.clinimag.2025.110615.
   PubMed        
   
   

   
   Int J Cancer

5. SANTIAGO LR, Ladoukakis E, Scibior-Bentkowska D, Nedjai B, et al
   Polygenic risk score and prostate specific antigen predict death from prostate cancer in men with intermediate aggressive cancer.
   Int J Cancer. 2025 Sep 16. doi: 10.1002/ijc.70163.
   PubMed         Abstract available
   
   
6. CHOPRA R, Li H, Xie W, Lam DHT, et al
   Arrhythmic expression signatures of circadian clock-associated transcription factors and chronic circadian disruption contribute to advanced prostate cancer growth.
   Int J Cancer. 2025 Sep 15. doi: 10.1002/ijc.70149.
   PubMed         Abstract available
   
   

   
   Int J Urol

7. HATANO K
   Editorial Comment on "Nomogram for Predicting the Survival Outcome of Cabazitaxel Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multi-Institutional Analysis".
   Int J Urol. 2025 Sep 17. doi: 10.1111/iju.70236.
   PubMed        
   
   
8. NAKAJIMA Y, Hashimoto K, Shindo T, Kobayashi K, et al
   Prostate-Specific Antigen Dynamics and Bone Predominance as Predictors of Efficacy in Radium-223 Treatment for Castration-Resistant Prostate Cancer.
   Int J Urol. 2025 Sep 16. doi: 10.1111/iju.70229.
   PubMed        
   
   

   
   J Magn Reson Imaging

9. SUNDARAM KM, Sagreiya H, Rosen MA
   Editorial for "Preoperative Assessment of Extraprostatic Extension in Prostate Cancer Using an Interpretable Tabular Prior-Data Fitted Network-Based Radiomics Model From MRI".
   J Magn Reson Imaging. 2025 Sep 13. doi: 10.1002/jmri.70115.
   PubMed        
   
   

   
   Nat Rev Urol

10. HENNES D, Al-Khanaty A, Chen DC, Dinneen E, et al
    End of the TRUS era: transperineal biopsy takes the lead in prostate cancer detection.
    Nat Rev Urol. 2025 Sep 15. doi: 10.1038/s41585-025-01090.
    PubMed        
    
    

    
    PLoS One

11. WANG W, Xie G, Wu Z
    Development of a prostate cancer biochemical recurrence risk signature using machine learning and motor protein-related genes.
    PLoS One. 2025;20:e0332747.
    PubMed         Abstract available
    
    

    
    Prostate

12. 
    Correction to "Resveratrol Inhibits the Tumor Migration and Invasion by Upregulating TET1 and Reducing TIMP2/3 Methylation In Prostate Carcinoma Cells".
    Prostate. 2025 Sep 14. doi: 10.1002/pros.70047.
    PubMed        
    
    

    
    Urology

13. SLOTA J, Naser-Tavakolian A, Ji E, Driscoll C, et al
    Economic Burden of Urinary Incontinence in Men with Prostate Cancer: Results from the Medical Expenditure Panel Survey (2016-2021).
    Urology. 2025 Sep 12:S0090-4295(25)00884-2. doi: 10.1016/j.urology.2025.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.